Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07676136 · ClinicalTrials.gov registry record · NA
A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT07676136: Clinical Trial NA study, sponsored by Stanford University.
NCT07676136 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07676136, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the effectiveness of recorded gut-directed hypnosis to an educational recording in people with chronic problems in their gastrointestinal (GI) system. Patients who are hospitalized at Stanford Hospital for worsening pain and/or nausea will be considered for enrollment.
Primary Outcome
Recruitment rate is the proportion enrolled among eligible patients approached.
Interventions
- BEHAVIORAL Gut directed hypnotherapy via telephone intervention
- BEHAVIORAL Educational recording
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-07 |
| Phase | NA |
What is known before NCT07676136 opens enrollment
NCT07676136 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Gut directed hypnotherapy via telephone intervention is the first listed.
NCT07676136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07676136 about?
NCT07676136 is a clinical study titled "A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients". The purpose of the study is to compare the effectiveness of recorded gut-directed hypnosis to an educational recording in people with chronic problems in their gastrointestinal (GI) system. Patients who are hospitalized at Stanford Hospital for worsening pain and/or nausea will be considered for enr...
What is the current status of trial NCT07676136?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2026-07. Estimated completion is 2028-07.
What interventions are being tested in trial NCT07676136?
The interventions under investigation include: Gut directed hypnotherapy via telephone intervention (BEHAVIORAL), Educational recording (BEHAVIORAL).
Who is sponsoring clinical trial NCT07676136?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07676136's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia